Ionetix Appoints Paul Surdez as Head of Investor Relations

– New role supports Ionetix’s transition to the public markets as the Company scales radioisotope production and expands R&D – LANSING, Mich., August 17, 2026 – Ionetix Corporation (“Ionetix” or the “Company”), a manufacturer of proprietary superconducting cyclotrons and producer of medical isotopes for diagnostic imaging and targeted alpha therapy, today announced the appointment of […] The post Ionetix Appoints Paul Surdez as Head of Investor Relations appeared first on Ionetix .